Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

Board appointment

19 Jul 2019 07:00

RNS Number : 0567G
Induction Healthcare Group PLC
19 July 2019
 

19 July 2019

 

Induction Healthcare Group plc

 

("Induction", the "Company or the "Group")

 

Board appointment

 

Induction Healthcare Group PLC, a leading healthcare technology company helping streamline the delivery of care, is pleased to announce the appointment of Leslie-Ann Reed to the Board as Non-Executive Director with effect from 19 July 2019.

 

Leslie-Ann adds breadth and depth to the Board as the Group continues to establish a strong and engaged user base and pursue its strategy to acquire new and complementary modules for the Induction Switch app.

 

Leslie-Ann is a chartered accountant with a diverse background and extensive international experience, having served in both executive and non-executive roles in publicly listed media and professional services companies. Leslie-Ann is currently Non-Executive Director and Chair of the Audit Committee for Learning Technologies Group plc, a market-leading integrated digital services and talent management provider. In addition, she is a Non-Executive Director at Bloomsbury Publishing plc, where she is a member of the Audit and Remuneration Committees. Previously, Leslie-Ann was a Non-Executive Director of the German listed company ZEAL Networks SE where she was Vice Chair of the Supervisory Board and Chaired the Audit Committee. Until May 2018 she was a Non-Executive Director and Chair of the Audit Committee of the London listed publisher Quarto Group, Inc.

 

From 2010 to 2012 she was Chief Financial Officer of the global, online B2B auctioneer Go Industry Dove Bid plc, which operated in 20 countries, where she focused on driving operating efficiencies, enhancing operating margins, improving cashflow and negotiating new banking facilities. She led the successful sale of the business in 2012. Between 2007 and 2010 Leslie-Ann was an adviser to Marwyn Investment Management, overseeing the strategy to acquire professional training, research, data and information businesses. Prior to that, she served as Chief Financial Officer of global commodities and economic research media group Metal Bulletin plc helping to lead its transition from printed products to an online data and news service. She played an important role in driving strong organic and acquisitive growth and in materially improving shareholder value, which ultimately led to its acquisition by Euromoney Institutional Investor PLC.

 

Leslie-Ann also held senior finance leadership roles at Universal Pictures, Polygram Music, EMI Music and Warner Communications Inc.

 

In accordance with Listing Rule LR 9.6.13 (1) Leslie-Ann Reed has held no other directorships in any other publicly quoted company at any time in the previous five years, except as disclosed above. There is no further information to disclose in respect of LR 9.6.13.

 

Leslie-Ann Reed does not have an interest to be disclosed in the shares of the Group.

 

Ibs Mahmood, CEO at Induction, said: 

 

"We are thrilled to welcome Leslie-Ann to our Board. Leslie-Ann's experience working with high growth and acquisitive companies will prove invaluable as we look to further grow our user base and app functionality, as well as looking at acquisition opportunities."

 

Leslie-Ann Reed said:

 

"I am very excited to get started at Induction. They've developed the Induction Switch app which is already changing the way medical professionals work to deliver care more effectively. I look forward to working with the team to help consolidate a fragmented market and to deliver on the strategy.

 

Save as disclosed below, in relation to current and prior directorships, Induction confirms that there are no further disclosures to be made in relation to Rule 17 of paragraph (g) of Schedule Two of the AIM Rules for Companies in respect of Leslie-Ann Reed's appointment.

 

Leslie-Ann Reed, aged 60, currently holds and has held the following directorships in the past five years:

Current directorships:

Bloomsbury Publishing Plc

Learning Technologies Group Plc

 

Directorships in the past five years:

Options Limited

Quarto Group Inc(The)

Zeal Network SE

 

Leslie-Ann Reed does not hold any ordinary shares of 0.5 pence each in the Company.

 

 

-Ends-

 

ENQUIRIES

 

Induction Healthcare

Ibs Mahmood, Chief Executive Officer

Seb Jantet, Chief Financial Officer

 

Via FTI Consulting

Numis Securities (Nominated Adviser and Broker)

James Black / Freddie Barnfield / Huw Jeremy / Matthew Jones

 

+44 (0) 207 260 1000

FTI Consulting

Brett Pollard / Jamie Ricketts / Elena Kalinskaya / Sam Purewal

+44 (0) 203 727 1000

 

 

About Induction

Induction Healthcare Group PLC is a leading healthcare technology company focused on helping healthcare professionals to streamline the delivery of care. The Group's technology enables healthcare professionals to save time and deliver care more effectively and to identify ways to allocate resources more efficiently.

The Group is initially targeting improving the way healthcare professionals communicate with each other through its Induction Switch app that provides a telephone directory (allowing healthcare professionals to easily find extension numbers), messaging and an administration portal (to share and view hospital guidelines), all in a secure and regulatory compliant setting.

As at 28 February 2019, the Induction Switch app had over 76,200 registered users, primarily in the UK, including over 50,500 doctors, GPs and consultants, 14,700 nurses and just under 11,000 other healthcare professionals. The registered user base grew by 42% over the six months to 28 February 2019.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGGUBGMUPBUPB
Date   Source Headline
17th Apr 20253:00 pmRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 20253:00 pmRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 202511:55 amRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 202510:51 amRNSForm 8.5 (EPT/RI)
17th Apr 20257:00 amRNSPublication of Scheme Document
16th Apr 202510:50 amRNSForm 8.5 (EPT/RI)
11th Apr 20252:29 pmEQSForm 8.3 - Induction Healthcare Group PLC - Opening Position Disclosure
11th Apr 202511:46 amRNSForm 8.5 (EPT/RI)
11th Apr 202511:14 amRNSForm 8.3 - Induction Healthcare Group Plc
10th Apr 202512:45 pmRNSRecommended Cash Acquisition
9th Apr 20256:15 pmRNSDirectorate Change
28th Jan 20257:00 amRNSBlock listing Interim Review
2nd Dec 20247:00 amRNSNew Contract in Republic of Ireland
5th Nov 20247:00 amRNSHalf-year Report
30th Oct 20247:00 amRNSMaterial new contract & Notice of Interim Results
13th Aug 20241:29 pmRNSResult of AGM
29th Jul 202410:00 amRNSBlock Listing Six Monthly Return
17th Jul 20247:00 amRNSGrant of Options
4th Jul 20247:00 amRNSFinal Results
1st Jul 202411:07 amRNSAMENDMENT: DIVESTMENT OF HORIZON
1st Jul 20247:00 amRNSDIVESTMENT OF HORIZON STRATEGIC PARTNERS LIMITED
27th Jun 20247:00 amRNSPublication of Full Year Financial Results Delayed
29th Apr 20247:00 amRNSFull Year Trading Update
29th Jan 20247:00 amRNSBlock listing Interim Review
7th Nov 20237:00 amRNSHalf-year Report
10th Oct 20237:00 amRNSUpdate on NHS National Portals Contracts
31st Jul 20233:13 pmRNSBlock listing Interim Review
31st Jul 20237:00 amRNSAudited Final Results
30th Jun 20237:00 amRNSBoard Changes and Trading Update
18th Apr 20237:00 amRNSTrading Update for year ending 31 March 2023
27th Jan 20237:00 amRNSBlock Listing Six Monthly Return
17th Jan 20237:00 amRNSChange of Registered Office
16th Jan 202312:20 pmRNSDirector/PDMR Shareholding
11th Jan 202312:52 pmRNSResults of 2022 Annual General Meeting
9th Jan 20237:00 amRNSDirectorate Changes
20th Dec 20227:00 amRNSChange of Auditor
20th Dec 20227:00 amRNSNotice of AGM
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20227:01 amRNSDirectorate Changes
5th Dec 20227:00 amRNSHalf-year Report
29th Nov 202212:01 pmEQSInduction Healthcare Group focused on 'building out core capability'
28th Nov 20227:01 amRNSNotice of Half-year results
28th Nov 20227:00 amRNSAudited Final Results
24th Oct 20227:00 amRNSUpdate on publication of Audited Final Results
22nd Sep 20227:00 amRNSExtension to 2022 annual reporting deadline

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.